CN104147349A

CN104147349A - Traditional Chinese medicinal composition for treating aplastic anemia

Info

Publication number: CN104147349A
Application number: CN201410404656.XA
Authority: CN
Inventors: 马永波
Original assignee: Individual
Current assignee: Individual
Priority date: 2014-08-18
Filing date: 2014-08-18
Publication date: 2014-11-19

Abstract

The invention relates to a traditional Chinese medicinal composition for treating aplastic anemia. The composition comprises, by weight, 30-40 parts of wolfberry fruit, 10-20 parts of Radix Puerariae, 20-30 parts of red ginseng, 30-40 parts of licorice root, 50-60 parts of Radix Astragali, 50-60 parts of Polygonum multiflorum, 50 parts of dry bovine bone marrow, 30-40 parts of charred human hair, 80-100 parts of donkey-hide gelatin, 30-40 parts of cornu cervi degelatinatum, 40-50 parts of Radix Pseudostellariae, 20-30 parts of Cordyceps sinensis, 20-30 parts of Salvia miltiorrhiza, 60-70 parts of tortoiseshell, 20-30 parts of Radix Ophiopogonis, 20-30 parts of Rhizoma Alismatis, 60-80 parts of honeysuckle flower, 10-20 parts of spirulina and 30-40 parts of pomegranate rind. The medicinal composition has the advantages of obvious aplastic anemia treatment effect, high cure rate, small daily dosage, and reduction of toxic side effects due to long term administration.

Description

A kind of Chinese medicine composition for the treatment of aplastic anemia

technical field:

The present invention relates to a kind of aplastic anemia Chinese medicine composition for the treatment of, particularly a kind of pharmaceutical composition for the treatment of acute aplastic anemia, chronic aplastic anemia.

background technology:

Aplastic anemia (abbreviation aplastic anemia) typically refers to constitutional marrow hematopoiesis function failure syndrome.The clinical symptoms of aplastic anemia shows as pale complexion, lethargy, myasthenia of limbs dizzy margins of eyelids, headache, cardiopalmus, insomnia, night sweat, breathes hard, and the asthenia internal injuries such as tongue, lip, nail colour dimness, subcutaneous have symptoms such as petechia that are dispersed in.Treatment on take nourish heart spleen invigorating tonification gas and nourishing the liver and kidney, fill out cloudy pathogenic fire reducing, hemostasis YANG hyperactivity suppressing is principle.

According to patient's the state of an illness, hemogram, bone marrow smear and prognosis, can be divided into heavy type (SAA) and non-heavy type (NSAA).Once there is scholar that non-heavy type is further divided into middle type and light-duty, from heavy type, separated extremely heavy (VSAA).Domestic scholars was once divided into AA acute (AAA) and chronic type (CAA).

Acute aplastic anemia onset is anxious, and rapidly, the hemorrhage and infectious fever of often take is main manifestations to progress.Sick just anemia is often not obvious, and main manifestations is digestive tract hemorrhage, heat in blood, retinal hemorrhage and intracranial hemorrhage, and skin, mucosal bleeding is extensive and serious and wayward.

Chronic aplastic anemia, onset is slow, take hemorrhage is first and main manifestations, hemorrhage be limited to mucocutaneous, and not serious, can accompanying infection, but often take respiratory tract as main, easily control.But also there is small number of patients delay not heal for many years, course of disease decades-long even, to the later stage, there is the clinical manifestation of acute aplastic anemia in minority.Be called chronic aplastic anemia sudden turn of events type.

summary of the invention:

The object of the present invention is to provide a kind of Chinese medicine composition for the treatment of aplastic anemia, this medicine composite for curing acute aplastic anemia, chronic aplastic anemia successful, cure highly, has no side effect.

The technical solution used in the present invention is: this treatment acute aplastic anemia, the pharmaceutical composition of chronic aplastic anemia comprises following component, each component is as follows by weight ratio: Fructus Lycii 30-40 part, Radix Puerariae 10-20 part, Radix Ginseng Rubra 20-30 part, Radix Glycyrrhizae 30-40 part, Radix Astragali 50-60 part, Radix Polygoni Multiflori 50-60 part, 50 parts of dry Medulla Bovis seu Bubali, Crinis Carbonisatus 30-40 part, Colla Corii Asini 80-100 part, Cornu Cervi Degelatinatum 30-40 part, Radix Pseudostellariae 40-50 part, Cordyceps 20-30 part, Radix Salviae Miltiorrhizae 20-30 part, Carapax et Plastrum Testudinis 60-70 part, Radix Ophiopogonis 20-30 part, Rhizoma Alismatis 20-30 part, Flos Lonicerae 60-80 part, spirulina 10-20 part, Pericarpium Granati 30-40 part.

By the Fructus Lycii of said ratio, Radix Puerariae, Radix Ginseng Rubra, Radix Glycyrrhizae, the Radix Astragali, Radix Polygoni Multiflori, dry Medulla Bovis seu Bubali, Crinis Carbonisatus, Colla Corii Asini, Cornu Cervi Degelatinatum, Radix Pseudostellariae, Cordyceps, Radix Salviae Miltiorrhizae, Carapax et Plastrum Testudinis, Radix Ophiopogonis, Rhizoma Alismatis, Flos Lonicerae, spirulina, warm water cleaning, sterilizing for Pericarpium Granati, 40 ℃ of vacuum dryings, be ground into fine powder, excessively after 200 mesh sieves, be distributed into 10 grams of portions and package stand-by.Dry Medulla Bovis seu Bubali is wherein by Medulla Bovis seu Bubali cold drying.Adult once a day, each one bag, child according to the body weight of self, reduce by half or the next day take.

The invention has the beneficial effects as follows: the effect of drugs of applying this treatment aplastic anemia is obvious, cure highly, and it is little day to take dosage, has reduced the toxic and side effects because of long-term taking.

the specific embodiment:

Below in conjunction with embodiment, the invention will be further described:

Embodiment 1, by 30 grams of Fructus Lycii, 10 grams of Radix Puerariaes, 20 grams of Radix Ginseng Rubra, 30 grams, Radix Glycyrrhizae, 50 grams of the Radixs Astragali, 50 grams of Radix Polygoni Multiflori, 50 grams of dry Medulla Bovis seu Bubali, 30 parts of Crinis Carbonisatus, 80 grams, Colla Corii Asini, 30 grams of Cornu Cervi Degelatinatums, 40 grams of Radix Pseudostellariaes, 20 grams of Cordyceps, 20 grams of Radix Salviae Miltiorrhizaes, 60 grams of Carapax et Plastrum Testudiniss, 20 grams of Radix Ophiopogonis, 20 grams of Rhizoma Alismatis, 60 grams of Flos Loniceraes, 10 grams of spirulinas, use warm water cleaning, sterilizing after 30 grams of mixing of Pericarpium Granati, 40 ℃ of vacuum dryings, are ground into fine powder, excessively after 200 mesh sieves, are distributed into 10 grams of portions and package stand-by.Be suitable for Children with Aplastic Anemia patient.

Embodiment 2, by 35 grams of Fructus Lycii, 15 grams of Radix Puerariaes, 25 grams of Radix Ginseng Rubra, 35 grams, Radix Glycyrrhizae, 55 grams of the Radixs Astragali, 55 grams of Radix Polygoni Multiflori, 85 grams, Colla Corii Asini, 35 grams of Cornu Cervi Degelatinatums, 50 grams of dry Medulla Bovis seu Bubali, 35 grams of Crinis Carbonisatus, 45 grams of Radix Pseudostellariaes, 25 grams of Cordyceps, 25 grams of Radix Salviae Miltiorrhizaes, 65 grams of Carapax et Plastrum Testudiniss, 25 grams of Radix Ophiopogonis, 25 grams of Rhizoma Alismatis, 65 grams of Flos Loniceraes, 15 grams of spirulinas, use warm water cleaning, sterilizing after 35 grams of mixing of Pericarpium Granati, 40 ℃ of vacuum dryings, are ground into fine powder, excessively after 200 mesh sieves, are distributed into 10 grams of portions and package stand-by.Be suitable for acute aplastic anemia patient or heavier patient.

Embodiment 3, by 40 grams of Fructus Lycii, 20 grams of Radix Puerariaes, 30 grams of Radix Ginseng Rubra, 40 grams, Radix Glycyrrhizae, 60 grams of the Radixs Astragali, 60 grams of Radix Polygoni Multiflori, 100 grams, Colla Corii Asini, 50 grams of dry Medulla Bovis seu Bubali, 40 grams of Crinis Carbonisatus, 40 grams of Cornu Cervi Degelatinatums, 50 grams of Radix Pseudostellariaes, 30 grams of Cordyceps, 30 grams of Radix Salviae Miltiorrhizaes, 70 grams of Carapax et Plastrum Testudiniss, 30 grams of Radix Ophiopogonis, 30 grams of Rhizoma Alismatis, 80 grams of Flos Loniceraes, 20 grams of spirulinas, use warm water cleaning, sterilizing after 40 grams of mixing of Pericarpium Granati, 40 ℃ of vacuum dryings, are ground into fine powder, excessively after 200 mesh sieves, are distributed into 10 grams of portions and package stand-by.Be suitable for Chronic Aplastic Anemia Patients.

Be one month each course for the treatment of, and Chronic Aplastic Anemia Patients will be fully recovered three courses for the treatment of, and acute or Patients with Severe Aplastic Anemia needs be almost recovered six courses for the treatment of.

The clinical effectiveness statistics of this medicine is in Table 1:

Table 1

Above data show that important composition prepared by the present invention has good curative effect to aplastic anemias such as chronic aplastic anemia, acute or aplastic anaemias.

Claims

1. a Chinese medicine composition for the treatment of aplastic anemia, it is characterized in that in this pharmaceutical composition, each component is as follows by weight ratio: Fructus Lycii 30-40 part, Radix Puerariae 10-20 part, Radix Ginseng Rubra 20-30 part, Radix Glycyrrhizae 30-40 part, Radix Astragali 50-60 part, Radix Polygoni Multiflori 50-60 part, 50 parts of dry Medulla Bovis seu Bubali, Crinis Carbonisatus 30-40 part, Colla Corii Asini 80-100 part, Cornu Cervi Degelatinatum 30-40 part, Radix Pseudostellariae 40-50 part, Cordyceps 20-30 part, Radix Salviae Miltiorrhizae 20-30 part, Carapax et Plastrum Testudinis 60-70 part, Radix Ophiopogonis 20-30 part, Rhizoma Alismatis 20-30 part, Flos Lonicerae 60-80 part, spirulina 10-20 part, Pericarpium Granati 30-40 part.